Inventor
GRAY JOHN DIXON
US34 patents
⚠️ This page may combine multiple inventors who share the name “GRAY JOHN DIXON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SORRENTO THERAPEUTICS INC
30 patentsUS10058609B2Aug 28, 2018
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC17 citations93
US9676853B2Jun 13, 2017
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC15 citations92
US10233251B2Mar 19, 2019
Antibody therapeutics that bind CD137
SORRENTO THERAPEUTICS INC7 citations84
US10100118B2Oct 16, 2018
Antibody therapeutics that bind CD123
SORRENTO THERAPEUTICS INC6 citations84
US10059774B2Aug 28, 2018
Antibody therapeutics that bind CD38
SORRENTO THERAPEUTICS INC6 citations84
US10035855B2Jul 31, 2018
Antibody therapeutics that bind CD47
SORRENTO THERAPEUTICS INC8 citations84
US10377827B2Aug 13, 2019
Antigen binding proteins that bind c-met
SORRENTO THERAPEUTICS INC14 citations83
US11180568B2Nov 23, 2021
Antibody therapeutics that bind CD137
SORRENTO THERAPEUTICS INC3 citations73
US10934361B2Mar 2, 2021
Antibody therapeutics that bind CD123
SORRENTO THERAPEUTICS INC2 citations73
US10800852B2Oct 13, 2020
Antibody therapeutics that bind CD38
SORRENTO THERAPEUTICS INC3 citations73
US9951144B2Apr 24, 2018
Antibody therapeutics that bind CD38
SORRENTO THERAPEUTICS INC2 citations73
US9902772B2Feb 27, 2018
Antibody therapeutics that bind LAG3
SORRENTO THERAPEUTICS INC5 citations73
US12084503B2Sep 10, 2024
Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment
SORRENTO THERAPEUTICS INC2 citations72
US10584168B2Mar 10, 2020
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC1 citations72
US9315579B2Apr 19, 2016
Antigen binding proteins that bind CCR2
SORRENTO THERAPEUTICS INC3 citations71
US9873741B2Jan 23, 2018
Antibody therapeutics that bind TIM3
SORRENTO THERAPEUTICS INC2 citations68
US11999792B2Jun 4, 2024
Antibody therapeutics that bind CD38
SORRENTO THERAPEUTICS INC0 citations62
US11878058B2Jan 23, 2024
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US11746156B2Sep 5, 2023
Antibody therapeutics that bind CD123
SORRENTO THERAPEUTICS INC0 citations62
US11242391B2Feb 8, 2022
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC0 citations62
US11155623B2Oct 26, 2021
Antibody therapeutics that bind CTLA4
SORRENTO THERAPEUTICS INC1 citations62
US11111304B2Sep 7, 2021
Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2)
SORRENTO THERAPEUTICS INC0 citations62
US11027012B2Jun 8, 2021
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US10202453B2Feb 12, 2019
Antibody therapeutics that bind CTLA4
SORRENTO THERAPEUTICS INC1 citations62
US11155628B2Oct 26, 2021
Antigen binding proteins that bind c-Met
SORRENTO THERAPEUTICS INC0 citations60
US11191845B2Dec 7, 2021
CD38 antibody drug conjugate
SORRENTO THERAPEUTICS INC0 citations58
US10927171B2Feb 23, 2021
Antibody therapeutics that bind TIM3
SORRENTO THERAPEUTICS INC0 citations58
US10696746B2Jun 30, 2020
Antigen binding proteins that bind CCR2
SORRENTO THERAPEUTICS INC0 citations51
US9951138B2Apr 24, 2018
Antigen binding proteins that bind CCR2
SORRENTO THERAPEUTICS INC0 citations51
US9944707B2Apr 17, 2018
Antibodies that bind epidermal growth factor receptor (EGFR)
SORRENTO THERAPEUTICS INC1 citations51